comparing cardiovascular and kidney outcomes with tirzepatide vs. glp-1 agonists Bridging the gap between GLP1-receptor outcomes: evidence for the role of | Cardiovascular Diabetology comparing cardiovascular and kidney outcomes

PAXLOVID may cause serious side effects, including: Allergic reactions, including severe allergic reactions (anaphylaxis)

Gradual Dose Increase: Sometimes, starting with a lower dose of semaglutide and gradually increasing it can help your body adjust to the medication

Mengqi Wang from the College of Chemistry and Chemical Engineering at Weifang University and dissolved with the basic semen extender as the working solution

What This New Study Found Between Semaglutide (Ozempic, Wegovy), Tirzepatide (Mounjaro, Zepbound), and Stroke Risk A new cohort study published July 2025 in JAMA Network Open followed over 60,000 adults with both type 2 diabetes and obesity

When GLP-1 drugs are started or stopped without proper clinical assessment, follow-up and lifestyle support, patients may experience rebound weight gain and other health complications

Gimme Care is a direct-to-consumer telehealth GLP-1 provider that prescribes compounded semaglutide and tirzepatide online, with medication shipped directly to patients